NAFLD and NASH are often associated with insulin resistance, glucotoxicity and accompanied by an increase in cholesterol, triglycerides, insulin, as well as decrease in adiponectin [12]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.